• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

优因汤治疗韩国肥胖女性的疗效和安全性:一项随机、双盲、安慰剂对照、多中心试验。

Efficacy and safety of Euiiyin-tang in Korean women with obesity: A randomized, double-blind, placebo-controlled, multicenter trial.

机构信息

Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University, Kyungheedae-ro 26, Dongdaemun-gu, Seoul 02447, Republic of Korea.

Department of Korean Medicine Rehabilitation, College of Korean Medicine, Gachon University, 1342 Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea.

出版信息

Complement Ther Med. 2020 Jun;51:102423. doi: 10.1016/j.ctim.2020.102423. Epub 2020 May 21.

DOI:10.1016/j.ctim.2020.102423
PMID:32507436
Abstract

BACKGROUND

Obesity is a global health problem and its incidence is on the rise. Euiiyin-tang is an herbal medicinal formula that is often used in the clinical treatment of obesity. The purpose of the present study was to evaluate the efficacy and safety of Euiiyin-tang in obesity treatment.

METHODS

A randomized, double-blind, placebo-controlled, multicenter trial was conducted. Participants with obesity were randomly assigned to receive Euiiyin-tang or placebo 3 times daily for 12-weeks. The primary outcome was weight reduction between the baseline and 12 weeks. The secondary outcomes included the rate of weight loss compared to baseline, and changes in body mass index, lipid profiles, and questionnaires related to the quality of life and diet. Safety factors, such as vital signs and laboratory parameters, were also measured.

RESULTS

A total of 149 participants were randomly distributed to either the Euiiyin-tang group (n = 76) or the placebo group (n = 73). Weight reduction in the Euiiyin-tang group was significantly greater than that in the placebo group (2.50 kg in the Euiiyin-tang group vs. 0.82 kg in the placebo group). The participant response rates of ≥3% weight loss compared to baseline was 36.8 % in the Euiiyin-tang group and 17.8 % in the placebo group. Body mass index, waist circumference, and hip circumference showed a greater change in the Euiiyin-tang group than in the placebo group (1.00, 3.23, and 2.00 in the Euiiyin-tang group vs. 0.33, 1.96, and 0.86 in the placebo group). Questionnaires, lipid profiles, and safety factors did not show significant differences between groups.

CONCLUSION

The results of this study suggest that Euiiyin-tang has beneficial effects on weight loss.

TRIAL REGISTRATION

Clinicaltrials.gov NCT01724099.

摘要

背景

肥胖是一个全球性的健康问题,其发病率呈上升趋势。惠阴汤是一种常用于临床肥胖治疗的草药配方。本研究旨在评估惠阴汤治疗肥胖的疗效和安全性。

方法

进行了一项随机、双盲、安慰剂对照、多中心试验。将肥胖参与者随机分为 3 次/d 接受惠阴汤或安慰剂治疗,疗程 12 周。主要结局为基线至 12 周时体重减轻量。次要结局包括与基线相比的体重减轻率,以及体重指数、血脂谱和与生活质量和饮食相关的问卷的变化。还测量了生命体征和实验室参数等安全因素。

结果

共有 149 名参与者被随机分配到惠阴汤组(n=76)或安慰剂组(n=73)。惠阴汤组的体重减轻量明显大于安慰剂组(惠阴汤组 2.50kg,安慰剂组 0.82kg)。惠阴汤组与基线相比≥3%体重减轻的参与者应答率为 36.8%,安慰剂组为 17.8%。惠阴汤组的体重指数、腰围和臀围变化大于安慰剂组(惠阴汤组 1.00、3.23 和 2.00,安慰剂组 0.33、1.96 和 0.86)。两组之间的问卷、血脂谱和安全因素没有显示出显著差异。

结论

本研究结果表明,惠阴汤对减肥有有益的作用。

试验注册

Clinicaltrials.gov NCT01724099。

相似文献

1
Efficacy and safety of Euiiyin-tang in Korean women with obesity: A randomized, double-blind, placebo-controlled, multicenter trial.优因汤治疗韩国肥胖女性的疗效和安全性:一项随机、双盲、安慰剂对照、多中心试验。
Complement Ther Med. 2020 Jun;51:102423. doi: 10.1016/j.ctim.2020.102423. Epub 2020 May 21.
2
Euiiyin-tang in the treatment of obesity: study protocol for a randomised controlled trial.莪术饮治疗肥胖症:一项随机对照试验的研究方案
Trials. 2017 Jun 21;18(1):289. doi: 10.1186/s13063-017-2039-8.
3
A pilot study exploring the efficacy and safety of herbal medicine on Korean obese women with metabolic syndrome risk factors: Double blinded, randomized, multicenter, placebo controlled study protocol clinical trial.一项探索草药对有代谢综合征风险因素的韩国肥胖女性的疗效和安全性的初步研究:双盲、随机、多中心、安慰剂对照研究方案临床试验。
Medicine (Baltimore). 2020 Jan;99(5):e18955. doi: 10.1097/MD.0000000000018955.
4
The efficacy and safety of Hanslim for obese patients: Study protocol for a multicenter, randomized, double-blind, multi-dose, placebo-controlled, phase IIb clinical trial.汉氏苗条素对肥胖患者的疗效与安全性:一项多中心、随机、双盲、多剂量、安慰剂对照的IIb期临床试验研究方案
Medicine (Baltimore). 2018 Sep;97(38):e12440. doi: 10.1097/MD.0000000000012440.
5
A pilot study to evaluate the effect of Taeumjowi-tang on obesity in Korean adults: study protocol for a randomised, double-blind, placebo-controlled, multicentre trial.一项评估当归芍药散对韩国成年人肥胖影响的初步研究:一项随机、双盲、安慰剂对照、多中心试验的研究方案。
Trials. 2012 Apr 7;13:33. doi: 10.1186/1745-6215-13-33.
6
Efficacy and safety of Onkyeong-tang in treating cold hypersensitivity in the feet of Korean women: protocol for a double-blind, randomized, placebo-controlled, parallel-group, multicenter clinical study.温经汤治疗韩国女性足部冷感过敏的疗效和安全性:一项双盲、随机、安慰剂对照、平行分组、多中心临床研究方案。
Trials. 2020 May 18;21(1):410. doi: 10.1186/s13063-020-04265-7.
7
Banha-sasim-tang as an herbal formula for the treatment of functional dyspepsia: a randomized, double-blind, placebo-controlled, two-center trial.八味散痛汤治疗功能性消化不良的随机双盲安慰剂对照两中心临床试验
Trials. 2010 Jul 30;11:83. doi: 10.1186/1745-6215-11-83.
8
Exploring the efficacy and safety of herbal medicine on Korean obese women with or without metabolic syndrome risk factors: A study protocol for a double-blind, randomized, multi-center, placebo-controlled clinical trial.探索草药对有或无代谢综合征风险因素的韩国肥胖女性的疗效和安全性:一项双盲、随机、多中心、安慰剂对照临床试验的研究方案。
Medicine (Baltimore). 2020 Jul 10;99(28):e21153. doi: 10.1097/MD.0000000000021153.
9
The efficacy and safety of Danggui-Sayuk-Ga-Osuyu-Saenggang-tang on Korean patients with cold hypersensitivity in the hands: study protocol for a pilot, double-blind, randomized, placebo-controlled, parallel-group clinical trial.当归芍药加吴茱萸生姜汤对韩国手部冷过敏患者的疗效和安全性:一项先导性、双盲、随机、安慰剂对照、平行组临床试验的研究方案
Trials. 2017 Jun 8;18(1):268. doi: 10.1186/s13063-017-2002-8.
10
Evaluation of the efficacy and safety of herbal medicine for treating work-related chronic low back pain: A study protocol for a multicenter, randomized, controlled, clinical trial.评估草药治疗与工作相关的慢性下腰痛的疗效和安全性:一项多中心、随机、对照临床试验的研究方案。
Medicine (Baltimore). 2019 Jul;98(30):e16466. doi: 10.1097/MD.0000000000016466.

引用本文的文献

1
Methodological insights into intervention and outcomes in randomised controlled trials of herbal medicine for obesity: a scoping review.草药治疗肥胖症随机对照试验中干预措施及结果的方法学见解:一项范围综述
Ther Adv Chronic Dis. 2025 Feb 4;16:20406223241310206. doi: 10.1177/20406223241310206. eCollection 2025.
2
Efficacy and safety of ephedra-containing oral medications: a systematic review, meta-analysis, and exploratory dose-response analysis for weight reduction.含麻黄碱口服药物的疗效与安全性:一项关于减肥的系统评价、荟萃分析及探索性剂量反应分析
Front Pharmacol. 2024 Oct 30;15:1397247. doi: 10.3389/fphar.2024.1397247. eCollection 2024.
3
Could Natural Products Help in the Control of Obesity? Current Insights and Future Perspectives.
天然产物能否有助于控制肥胖? 当前的见解和未来的展望。
Molecules. 2023 Sep 13;28(18):6604. doi: 10.3390/molecules28186604.
4
Efficacy and safety of traditional chinese medicine treatment for overweight and obese individuals: A systematic review and meta-analysis.中药治疗超重和肥胖个体的疗效与安全性:一项系统评价和荟萃分析。
Front Pharmacol. 2022 Oct 5;13:964495. doi: 10.3389/fphar.2022.964495. eCollection 2022.
5
A national survey on current clinical practice pattern of Korean Medicine doctors for treating obesity.一项关于韩国医师治疗肥胖的临床实践现状的全国性调查。
PLoS One. 2022 Mar 24;17(3):e0266034. doi: 10.1371/journal.pone.0266034. eCollection 2022.
6
The Effects and Safety of Chinese Herbal Medicine on Blood Lipid Profiles in Placebo-Controlled Weight-Loss Trials: A Systematic Review and Meta-Analysis.在安慰剂对照的减肥试验中,中草药对血脂谱的影响及安全性:一项系统评价和荟萃分析
Evid Based Complement Alternat Med. 2022 Jan 17;2022:1368576. doi: 10.1155/2022/1368576. eCollection 2022.